[Clinical studies of cefaclor for respiratory tract infections].

Abstract

Cefaclor (CCL) was administered to 27 patients with acute pneumonia and the following results were obtained. CCL was given 500 mg t. i. d. for 6 to 23 days. The clinical effects of CCL were excellent in 2 cases, good in 14 cases, fair in 6 cases and poor in 5 cases, the efficacy rate was 59.3%. No adverse reaction was observed. We conclude that CCL is considerably useful in the treatment of acute pneumonia of outpatients.

• Authors: Y Hiraga, K Kikuchi, A Yamamoto
• Journal: The Japanese journal of antibiotics (Jpn J Antibiot) Vol. 37 Issue 4 Pg. 581-8 (Apr 1984) ISSN: 0368-2781 [Print] Japan
• PMID: 6471379 (Publication Type: English Abstract, Journal Article)

Chemical References

• Cefaclor
• Cephalexin

Topics

• Acute Disease
• Administration, Oral
• Adult
• Aged
• Cefaclor (administration & dosage, adverse effects, therapeutic use)
• Cephalexin (analogs & derivatives)
• Drug Evaluation
• Female
• Humans
• Male
• Middle Aged
• Pneumonia (drug therapy)